Literature DB >> 14593115

Fibroblast growth factor-2 represses platelet-derived growth factor receptor-alpha (PDGFR-alpha) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-alpha promoter.

Michelle R Bonello1, Levon M Khachigian.   

Abstract

Platelet-derived growth factor (PDGF) is a potent mitogen and chemoattractant for vascular smooth muscle cells (SMCs) whose biological activity is mediated via its high affinity interaction with specific cell surface receptors. The molecular mechanisms governing the expression of PDGF receptor-alpha (PDGFR-alpha) are poorly understood. Here we demonstrate that PDGFR-alpha protein and transcriptional regulation in SMCs is under the positive regulatory influence of the zinc finger nuclear protein, Sp1. Electrophoretic mobility shift, competition, and supershift analysis revealed the existence of an atypical G-rich Sp1-binding element located in the PDGFR-alpha promoter -61 to -52 bp upstream of the transcriptional start site. Mutation of this sequence ablated endogenous Sp1 binding and activation of the PDGFR-alpha promoter. PDGFR-alpha transcription, mRNA, and protein expression were repressed in SMCs exposed to fibroblast growth factor-2 (FGF-2). This inhibition was rescued by the blockade of extracellular signal-regulated kinase-1/2 (ERK1/2). FGF-2 repression of PDGFR-alpha transcription was abrogated upon mutation of this Sp1-response element. FGF-2 stimulated Sp1 phosphorylation in an ERK1/2- but not p38-dependent manner, the growth factor enhancing Sp1 interaction with the PDGFR-alpha promoter. Mutation of residues Thr(453) and Thr(739) in Sp1 (amino acids phosphorylated by ERK) blocked FGF-2 repression of PDGFR-alpha transcription. These findings, taken together, demonstrate that FGF-2 stimulates ERK1/2-dependent Sp1 phosphorylation, thereby repressing PDGFR-alpha transcription via the -61/-52 element in the PDGFR-alpha promoter. Phosphorylation triggered by FGF-2 switches Sp1 from an activator to a repressor of PDGFR-alpha transcription, a finding previously unreported in any Sp1-dependent gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593115     DOI: 10.1074/jbc.M308254200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.

Authors:  J-Y Chuang; S-A Wang; W-B Yang; H-C Yang; C-Y Hung; T-P Su; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation.

Authors:  Xiao-Feng Lu; En-Min Li; Ze-Peng Du; Jian-Jun Xie; Zhang-Yan Guo; Shu-Ying Gao; Lian-Di Liao; Zhong-Ying Shen; Dong Xie; Li-Yan Xu
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

3.  Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.

Authors:  Ying Zhang; Mingjuan Liao; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 4.  Sp1 phosphorylation and its regulation of gene transcription.

Authors:  Nicole Y Tan; Levon M Khachigian
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

5.  Rac1-mediated mitochondrial H2O2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1.

Authors:  Shubha Murthy; Alan Ryan; Chao He; Rama K Mallampalli; A Brent Carter
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

6.  Insulin-like growth factor-I activates extracellularly regulated kinase to regulate the p450 side-chain cleavage insulin-like response element in granulosa cells.

Authors:  Larry Denner; Yvonne H Bodenburg; Jie Jiang; Gilles Pagès; Randall J Urban
Journal:  Endocrinology       Date:  2010-04-06       Impact factor: 4.736

7.  Regulation of EP4 expression via the Sp-1 transcription factor: inhibition of expression by anti-cancer agents.

Authors:  Atsushi Kambe; Genzo Iguchi; Yuseok Moon; Hideki Kamitani; Takashi Watanabe; Thomas E Eling
Journal:  Biochim Biophys Acta       Date:  2008-02-20

8.  Cell death or survival promoted by alternative isoforms of ErbB4.

Authors:  Maria Sundvall; Ville Veikkolainen; Kari Kurppa; Zaidoun Salah; Denis Tvorogov; E Joop van Zoelen; Rami Aqeilan; Klaus Elenius
Journal:  Mol Biol Cell       Date:  2010-10-13       Impact factor: 4.138

9.  The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.

Authors:  Atsushi Kambe; Hiroki Yoshioka; Hideki Kamitani; Takashi Watanabe; Seung Joon Baek; Thomas E Eling
Journal:  Cancer Prev Res (Phila)       Date:  2009-11-24

10.  Histone deacetylase-1 is enriched at the platelet-derived growth factor-D promoter in response to interleukin-1beta and forms a cytokine-inducible gene-silencing complex with NF-kappab p65 and interferon regulatory factor-1.

Authors:  Mary Y Liu; Levon M Khachigian
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.